https://ipsg.nelara.se 2026-09-24T08:35:55.906Z https://ipsg.nelara.se/upcoming 2026-09-24T08:35:55.906Z https://ipsg.nelara.se/past 2026-09-24T08:35:55.906Z https://ipsg.nelara.se/revisiting-non-factor-therapies 2026-09-23T21:45:08.632Z https://ipsg.nelara.se/imaging-of-haemophilia-an-update 2026-09-23T21:45:08.646Z https://ipsg.nelara.se/non-factor-therapies-from-mechanism-of-action-to-practical-implementation 2026-09-23T21:45:08.746Z https://ipsg.nelara.se/evidence-and-practical-management-of-subclinical-haemorrhage-in-haemophilia 2026-09-23T21:45:08.666Z https://ipsg.nelara.se/von-willebrand-disease-the-role-of-prophylaxis 2026-09-23T21:45:08.657Z https://ipsg.nelara.se/gene-therapy-the-ultimate-prophylaxis 2026-09-23T21:45:08.676Z https://ipsg.nelara.se/expert-working-group-reports 2026-09-23T21:45:08.778Z https://ipsg.nelara.se/immune-tolerance-induction-iti-in-the-current-treatment-era 2026-09-23T21:45:08.725Z https://ipsg.nelara.se/management-of-previously-untreated-patients-pups-with-severe-hemophilia-in-the-era-of-novel-hemostatic-therapies 2026-09-23T21:45:08.737Z